Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AngloGold Ashanti Limited (AU) vs Becton Dickinson and Co (BDX) Price & Performance

AngloGold Ashanti LimitedTrade
Becton Dickinson and CoTrade

Price performance (Past 24H)

Key statistics

AngloGold Ashanti Limited vs Becton Dickinson and Co — how do they compare? AngloGold Ashanti Limited trades at $98.67 (market cap $49.19B), while Becton Dickinson and Co trades at $181.29 (market cap $48.93B). The key difference: AngloGold Ashanti Limited and Becton Dickinson and Co are close in size by market cap, and AngloGold Ashanti Limited pays the higher dividend (4.65%). Which is the better fit depends on your goals.

AUBDX
Market Cap
$49.19B$48.93B
Sector
Basic MaterialsHealth
52-Week High
$128.26$185.39
52-Week Low
$52.15$138.62
Enterprise Value
$48.20B$65.03B
Dividend Yield
4.65%2.34%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AngloGold Ashanti Limited

AngloGold Ashanti (AU) surged 9.85% to $96.22 on strong gold price momentum and positive Q2 earnings. The stock trades near its 52-week high with bullish technical indicators and robust fundamentals including 26.64% net margins and 46.5% ROE. Recent quarterly results showed mixed performance with Q1 beating expectations while Q2 slightly missed, but strong free cash flow growth supports increased shareholder returns including dividends and a $2 billion buyback program.

Outlook remains positive with analyst consensus at $120.33 target (25% upside) and 64% buy ratings. Key catalysts include H2 production growth and gold price strength, while risks involve operational disruptions and commodity volatility. The company's improving balance sheet and cash generation support continued dividend payments and strategic initiatives.

Becton Dickinson and Co

BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.

The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AngloGold Ashanti Limited

Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.

Read more on AU

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX